25 January 2021 (Monday) - Myelofibrosis

The nice people at Medscape sent some information on myelofibrosis today. All rather more clinical than technical, but that can be said of most of the stuff I read these days… 

'Impressive' Results After Change of HSCT Conditioning Regimen in Myelofibrosis Patients

JAK1/2 Inhibitors Linked to Lymphoma Risk in Myelofibrosis

Pacritinib Can Fill Unmet Need in Myelofibrosis

FDA Approves Fedratinib for the Treatment of Myelofibrosis

No comments:

Post a Comment